According to IQVIA's latest financial reports the company's current earnings are $15.49 Billion USD. In 2024 the company made an earning of $2.33 Billion USD, an increase over its 2023 earnings that were of $2.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $2.32 B | -0.77% |
2024 | $2.33 B | 9.76% |
2023 | $2.13 B | 19.79% |
2022 | $1.77 B | 18.36% |
2021 | $1.50 B | 90.49% |
2020 | $0.78 B | -1.25% |
2019 | $0.79 B | 7.68% |
2018 | $0.74 B | 6.61% |
2017 | $0.69 B | 11.74% |
2016 | $0.62 B | -2.79% |
2015 | $0.64 B | 6.31% |
2014 | $0.60 B | 34.96% |
2013 | $0.44 B | 11.16% |
2012 | $0.40 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() NRC Health
NRC | $35.1 M | -98.49% | ๐บ๐ธ USA |
![]() Nymox Pharmaceutical NYMX | -$2.17 Million | -100.09% | Bahamas |